Source: Virtual Congress 2020 – Novel directions in pleural disease: bench to bedside
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
K. Li (Chongqing (Chongqing), China), Q. Zhao (Chongqing (Chongqing), China), P. Zhang (Chongqing (Chongqing), China). Efficacy of Pleurodesis and EGFR TKI in the Treatment of Lung Cancer-mediated Pleural Effusion with EGFR Mutation. 1148

Member's Comments

No comment yet.

Related content which might interest you: Treatment with Anti-VEGF and anti-EGFR in a model of malignant pleural effusion: Genic evaluation Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management Year: 2018 Activated KRAS signaling triggers malignant pleural effusion Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management Year: 2015 Targeting of CSF1R abrogates Lewis Lung adenocarcinoma-induced malignant pleural effusion Source: International Congress 2018 – Mesothelioma and pleural malignancy: investigations and management Year: 2018 Efficacy And Safety Of Thoracoscopic Cryobiopsy In Patients With Undiagnosed Exudative Pleural Effusion Source: Virtual Congress 2020 – Interventional pulmonology: the pleura and bronchoscopic treatment of emphysema Year: 2020 Hemorrhagic malignant pleural effusion: Diagnosis, survival rate, and response to talc pleurodesis Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Variation in outcomes for M1a Stage Lung cancers- Outcome in Malignant Pleural Effusion significantly worse than patients with Contralateral Lung Nodules Source: Virtual Congress 2021 – Accurate diagnosis and prediction of malignant pleural disease Year: 2021 Role of fibulin-3 in the diagnosis of malignant mesothelioma Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma Year: 2014 Validity of Pleural Fluid Protein in differentiating Tuberculous from Malignant Pleural Effusion Source: International Congress 2019 – Pleural infection and complicated pneumonia Year: 2019 Efficacy of recombinant adenoviral human p53 gene in treatment of lung cancer-mediated pleural effusion Source: International Congress 2015 – Emerging technologies for malignant pleural diseases management Year: 2015 Efficacy of Matrix Metalloproteinase-9 in Differentiating Tuberculous from Non-Tuberculous Pleural Effusion Source: International Congress 2019 – Tuberculosis: diagnosis Year: 2019 Elevated survivin is associated with a reduced survival in patients with malignant pleural effusion Source: Annual Congress 2013 –Fundamental biology of malignant pleural effusions Year: 2013 Half Dose Urokinase Can Be Effective in Patients with Complicated Parapneumonic Effusion. Source: International Congress 2017 – From microbiology to clinical work Year: 2017 The Effect on Chest Tube Drainage of Postoperative Prophylactic Enoxaparin in Patients with Non-small Cell Lung Cancer Source: International Congress 2018 – Lung cancer: new tools for diagnosis and patient assessment Year: 2018 Role of Dr-70 immunoassay in suspected malignant pleural effusion Source: Annual Congress 2013 –New methods for diagnostic workup of lung cancer Year: 2013 EPIToME (Early Pleurodesis via IPC with Talc for Malignant Effusion): Evaluation of a new management algorithm Source: International Congress 2019 – Novel approaches to pleural effusion: should I change my practice? Year: 2019 Predictive parameters of survival in malignant pleural effusion Source: International Congress 2015 – Malignant pleural effusions and mesothelioma Year: 2015 RNA is favourable for analysing EGFR mutations in malignant pleural effusion of lung cancer Source: Eur Respir J 2012; 39: 677-684 Year: 2012 Talc pleurodesis for malignant pleural effusion - effect on survival: Case-control follow-up study Source: International Congress 2014 – Diagnosis and treatment of pleural mesothelioma Year: 2014 Performance of Super ARMS to Detect EGFR Mutation Status in Plasma Cell-free DNA in Advanced Non-Small Cell Lung Cancer Patients Source: International Congress 2017 – Clinical research in lung cancer: new valuable results on lung cancer detection, prognostic biomarkers, and tyrosine kinase inhibitors Year: 2017